News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Mufti N. Ahmad, MD, FACP

Articles by Mufti N. Ahmad, MD, FACP

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors

ByKathryn F. Mileham, MD, FACP,Mufti N. Ahmad, MD, FACP,Edward S. Kim, MD, FACP

April 15th 2019

In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.

Latest Updated Articles

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors
April 15th 2019

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)